AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2020
Sep 10, 2020
34395_dirs_2020-09-10_f370a486-02e2-418b-855d-ef8b385a1b56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-09-09
Reporting Person: Faulkes Martin Charles (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-09 | Common Stock | S | 65000 | $3.21 | Disposed | 1505943 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 356000 | Indirect |
Footnotes
F1: The shares of Common Stock were sold by the reporting person in a private transaction to Lagoda Investment Management, L.P., an existing stockholder of the Issuer.
F2: These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. Mr. Faulkes serves as the chairman, director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1
Annual Report
2026
Mar 31